<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>R-CHOP chemotherapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/r-chop-chemotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 17:31:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>R-CHOP chemotherapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Exploring Dexamethasone Boost in DLBCL Treatment Efficacy</title>
		<link>https://bioengineer.org/exploring-dexamethasone-boost-in-dlbcl-treatment-efficacy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 17:31:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[Dexamethasone pre-phase]]></category>
		<category><![CDATA[DLBCL treatment strategies]]></category>
		<category><![CDATA[gastrointestinal involvement in cancer]]></category>
		<category><![CDATA[Gastrointestinal lymphoma]]></category>
		<category><![CDATA[İçeriğe en uygun 5 etiket: **DLBCL treatment]]></category>
		<category><![CDATA[Patient Safety]]></category>
		<category><![CDATA[pre-phase treatment protocols]]></category>
		<category><![CDATA[R-CHOP chemotherapy]]></category>
		<category><![CDATA[the 5 most appropriate and specific tags are: **dexamethasone in lymphoma therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-dexamethasone-boost-in-dlbcl-treatment-efficacy/</guid>

					<description><![CDATA[In a groundbreaking study published in Annals of Hematology, researchers led by Cui et al. explore an innovative treatment strategy for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) who exhibit gastrointestinal (GI) involvement at the onset of their condition. This particular group of cancer patients faces significant challenges due to the aggressive nature of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319930</post-id>	</item>
	</channel>
</rss>
